Search Within

Nursing

  1. "Haematologica"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
  3. Research Letter (2)
Groups
  1. Department of Medicine (8)
  2. Center for Hematologic Malignancies (7)
  3. Hematologic Malignancies, Division of (7)
  4. Executive Committee, Center for Hematologic Malignancies (5)
  5. Lymphoma (5)
  6. Advanced Practice Providers (4)

More Groups

People
  1. Anas Younes (4)
  2. Amanda Copeland (3)
  3. Craig Sauter (3)
  4. Ariela Noy (2)
  5. Connie Batlevi (2)
  6. John Gerecitano (2)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2018 (1)
  4. 2016 (3)
  5. 2015 (2)
  6. 2007 (1)
Publications
  1. Haematologica (9)
Publishers
  1. Ferrata Storti Foundation (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-reported fatigue and pain in Erdheim-Chester disease: A registry-based, mixed methods study
    Research Letter

    Reiner, A. S.; Bossert, D.; Buthorn, J. J.; Sigler, A. M.; Gonen, S.; Fournier, D.; Brewer, K.; Corkran, J.; Goyal, G.; Allen, C. E.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Phase 1 trial of CUDC-907, a novel, oral dual inhibitor of HDAC and Pi3k: Updated assessment of patients with relapsed or refractory diffuse large B-cell lymphoma, including double expressor lymphoma
    Meeting Abstract

    Younes, A.; Berdeja, J.; Patel, M.; Kelly, K.; Flinn, I.; Gerecitano, J.; Neelapu, S.; Copeland, A.; Wang, J.; Gong, L.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • ENGAGE-501: Phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Batlevi, C. L.; Kasamon, Y.; Bociek, R. G.; Lee, P.; Gore, L.; Copeland, A.; Sorensen, R.; Ordentlich, P.; Cruickshank, S.; Kunkel, L.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • A phase 1 trial of CUDC-907, an oral, first-in-class, dual inhibitor of HDAC and PI3K, in patients with refractory or relapsed lymphoma and multiple myeloma
    Meeting Abstract

    Oki, Y.; Berdeja, J.; Patel, M.; Flinn, I.; Gerecitano, J.; Neelapu, S.; Copeland, A.; Akins, A.; Clancy, M.; Viner, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Nursing guidelines for enhanced patient care
    Meeting Abstract

    Bertolotti, P.; Bilotti, E.; Colson, K.; Curran, K.; Doss, D.; Faiman, B.; Gavino, M.; Jenkins, B.; Lilleby, K.; Love, G.; more...
    Haematologica (2007)

    Fulltext@MSK | Save